OTC - ACTIVE INGREDIENT SECTION
Active ingredients Purpose
Zinc Oxide 24.5% Sunscreen
Active ingredients Purpose
Zinc Oxide 24.5% Sunscreen
Uses
Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.
Stop use and ask a doctor if rash occurs
Warnings
For external use only
Do not use on damaged or broken skin
When using this product keep out of eyes. Rinse with water to remove.
Directions
Inactive Ingredients
Calcium Aluminum Borosilicate, Silica, Polymethyl Methacrylate, Ethylhexylglycerin, Triethoxycaprylysilane, Nylon-6/12, Sodium Dehydroacetate, Olive Glycerides, Ascorbyl Palmitate, Ceramide 3. May contain +/- Iron Oxides (CI 77492, CI 77491, CI 77499), Titanium Dioxide (CI 77891)
Invincible Setting Powder SPF 45
100% Mineral + Sweat resistant
Light
0.15 oz./ 4.25 g
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 75936-146-02 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-68f2-a426-e053-dadaa90af4c2 | Invincible Setting Powder SPF 45 Light |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 75936-146-01 | Invincible Setting Powder SPF 45 Light | 4.25 g in 1 PACKAGE | POWDER | 4.25 | 1 | |
| 75936-146-02 | Invincible Setting Powder SPF 45 Light | 1 in 1 BOX | POWDER | 1 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 75936-146 | 75936-146-01, 75936-146-02 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 3e05f511-490b-4972-a705-c3184b438ebc | 4f7109d5-8ac1-419e-a4dc-ec0f45ab273c | 2018-01-15 | Warnings | 3e05f511-490b-4972-a705-c3184b438ebc 4f7109d5-8ac1-419e-a4dc-ec0f45ab273c |
Adverse event summaries are temporarily unavailable. Other product information remains available.